With Strand Life Sciences, Reliance is pushing genetic testing toward the mainstream. Incumbents, regulators and doctors are ...
Reliance Industries is set to disrupt the genomic diagnostics market by offering tests for under ₹1,000, significantly lowering costs and enhancing access to advanced healthcare solutions. The ...
Reliance Industries Ltd is preparing to introduce advanced genetic testing services at sharply reduced prices, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback